A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Fenproporex
Dexketoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Dexketoprofen.
Fenproporex
Benzydamine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Benzydamine.
Fenproporex
Epirizole
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Epirizole.
Fenproporex
Etofenamate
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Etofenamate.
Fenproporex
Fenbufen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Fenbufen.
Fenproporex
Floctafenine
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Floctafenine.
Fenproporex
Ibuproxam
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Ibuproxam.
Fenproporex
Indoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Indoprofen.
Fenproporex
Isoxicam
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Isoxicam.
Fenproporex
Kebuzone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Kebuzone.
Fenproporex
Salicylamide
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Salicylamide.
Fenproporex
Parecoxib
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Parecoxib.
Fenproporex
Azapropazone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Azapropazone.
Fenproporex
Zaltoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Zaltoprofen.
Fenproporex
Aceclofenac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Aceclofenac.
Fenproporex
Lornoxicam
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Lornoxicam.
Fenproporex
Cimicoxib
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Cimicoxib.
Fenproporex
Zomepirac
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Zomepirac.
Fenproporex
Metamizole
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Metamizole.
Fenproporex
Benoxaprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Benoxaprofen.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3